Search
Sharan Murugan
Apr 42 min read
USFDA: Guidance one eSubmission of Expedited Safety Reports From IND-Exempt BA/BE Studies and Data Integrity for In Vivo BA & BE studies
Today (04 April 2024) the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research released draft guidance on...
25 views0 comments
Sharan Murugan
Aug 2, 20221 min read
USFDA Guidance: Electronic Submission of Expedited Safety Reports From IND- Exempt BA/BE Studies
Today (August 2, 2022) FDA published draft guidance for the industry, “Electronic Submission of Expedited Safety Reports from IND-Exempt...
25 views0 comments
Sharan Murugan
Oct 3, 20211 min read
USFDA’s drafts “Investigator Responsibilities–Safety Reporting for Investigational Drugs & Devices
The U.S. Food and Drug Administration has released draft guidance for clinical trial investigators outlining their safety reporting...
21 views0 comments